SARS-CoV-2 Spike Protein RBD (KP.2 Variant) Neutralizing Antibody,Abbexa,abx422322

SARS-CoV-2 Spike Protein RBD (KP.2 Variant) Neutralizing Antibody is a Human Monoclonal antibody for the detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (KP.2 Variant).

Host

Human

Reactivity

Virus

Application

ELISA

Conjugate

Unconjugated

Platform ID

BAB276991562

Abbexa

Headquarters

181 Cambridge Science Park Cambridge, CB4 0GJ United Kingdom

Contact

Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951

Product Specifications

Specifications

NameSARS-CoV-2 Spike Protein RBD (KP.2 Variant) Neutralizing Antibody
Cat. No.abx422322
Accession NumberP0DTC2
HostHuman
IsotypeIgG1
ReactivityVirus
ConjugationUnconjugated
ApplicationELISA
Working DilutionsOptimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
Clone NumberJ552
Concentration3.17 mg/ml
TargetS
PurityPurified from cell culture supernatant by Protein A/G chromatography.
Appearance/FormLiquid
Formulation0.01 M PBS, pH 7.4.
StorageAliquot and store at 2-8°C for up to 2 weeks, or at -20°C for up to 1 year. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.